Tiny study tracks lidocaine levels in mastectomy patients
NCT ID NCT01687348
First seen May 11, 2026 · Last updated Jun 23, 2026 · Updated 8 times
Summary
This study looked at how the numbing drug lidocaine behaves in the body when given as a special type of local anesthesia for mastectomy. Researchers took blood samples from 6 women over 48 hours to measure lidocaine levels. The goal was to better understand the drug's safety and how it provides pain relief after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASTECTOMY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lidocaine
What this could lead to
If successful, this could help doctors use lidocaine more safely and effectively for mastectomy pain relief.
What could go wrong
This is a very small, early-phase study with only 6 participants. It focuses on drug levels, not on proving pain relief or safety in a larger population.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.